With three-year revenue growth of 1036 percent, Xevant ranks 28th overall among America’s Fastest-Growing Private Companies.
ReGelTec’s HYDRAFIL Technology Selected as Best Abstract Presentation at the American Society of Pain and Neuroscience Annual Meeting – Press Release
Congratulations to portfolio company Regenosine on receiving a $1.67M NIH NIAMS Phase II SBIR grant to commercially develop their disease modifying osteoarthritis drug. Read More
Tech Council Ventures is proud to share this impressive news that speaks volumes to the time and dedication Brandon puts forth to lead Xevant to
A BetterPlanet Experience in partnership with PSEG The second annual TechUnited:BetterPlanet Challenge will award one final winner a $50K prize and finalists exposure, press, and
View the original press release here. June 24, 2021 Draper — Xevant, leader in automated pharmacy benefits data analysis, wins Gold Globee® award as Start-Up
This episode presents three startups: PredictivCare (San Francisco); GenomicExpression (Beverly, MA); and Enroute (New York) with investor judges John Doll, Chief Financial & Administrative Officer,
Congratulations to portfolio company CareAlign CEO Subha Airan-Javia MD, FAMIA for winning the Sharp Index Award for Best Health Tech Innovator in Physician Burnout and
PO Box 307
Summit, NJ 07902
+1-856-273-6800
We invest in the most promising early-stage, rapid-growth technology companies in the Mid-Atlantic region.
© 2023 Tech Council Ventures, LLC. All Rights Reserved.
Website designed by Lookit® Design , powered by Lookit® QuikSite.
© 2023 Tech Council Ventures, LLC.
All Rights Reserved.
Website designed by Lookit® Design ,
powered by Lookit® QuikSite.
